OBERWEIS ASSET MANAGEMENT INC/

Position in CRMD — CorMedix Inc.

CIK 937886 LISLE, IL

Position in CRMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,392,732

+$2,169,262 QoQ

Shares Held

1,323,915

+9.3% QoQ

Ownership

1.70%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

of 194 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OBERWEIS ASSET MANAGEMENT INC/ holds $71,518,263 across 4 Biotechnology names. CRMD ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	1,372,941	$35,998,513
2	HALO	Halozyme Therapeutics, Inc.	321,030	$25,127,018
3	CRMD	CorMedix Inc. This page	1,323,915	$10,392,732
4			293,670	$0

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,392,732	1,323,915	+9.3%	Shares	Sole	2026-08-14
2026-03-31	$8,223,470	1,211,115	+50.4%	Shares	Sole	2026-05-15
2025-12-31	$9,363,487	805,115	+2.5%	Shares	Sole	2026-02-17
2025-09-30	$9,137,691	785,700	+62.0%	Shares	Sole	2025-11-17
2025-06-30	$5,975,200	485,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,987,600	485,000	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.